CTC researchers and their collaborators have a strong record of published research in prestigious international journals. Recent journal articles are listed here.

Use the search link below to find specific articles, or articles by year, author, trial or group, back to 2005.

Search for articles


Ameratunga M, Pavlakis N, Gebski V, Broad A, Khasraw M. Epidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: a meta-analysis. Asia Pacific Journal of Oncology 2014;  10 (3): 273–278.

Barz T, Melloh M, Lord SJ, Kasch R, Merkg HR, Staub LP. A conceptual model of compensation/ decompensation in lumbar segmental instability. Medical Hypotheses 2014;  83 (3): 312–316.

Barz T, Melloh M, Staub LP, Lord SJ, Lange J, Merk HR. Increased intraoperative epidural pressure in lumbar spinal stenosis patients with a positive nerve root sedimentation sign. European Spine Journal 2014;  23 (5): 985–990.

Barz T, Staub LP, Melloh M, Hamann G, Lord SJ, Chatfield MD, Bossuyt PM, Lange J, Merk HR. Clinical validity of the nerve root sedimentation sign in patients with suspected lumbar spinal stenosis. Spine Journal 2014;  14 (4): 667–674.

Basu A, Jenkins AJ, Stoner JA, Klein RL, Lopes-Virella MF, Garvey WT, Lyons TJ, DCCT/EDIC Research Group. Plasma homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study. Atherosclerosis 2014;  236 (1): 188–195.

Berlin JA, Morris S, Rockhold F, Askie L, Ghersi D, Waldstreicher J. Bumps and bridges on the road to responsible sharing of clinical trial data. Clinical Trials 2014;  11 (1): 7–12.

Beumer JD, Gill G, Campbell I, Wetzig N, Ung O, Farshid G, Uren R, Stockler M, Gebski V. Sentinel node biopsy and large (≥3 cm) breast cancer. ANZ Journal of Surgery 2014;  84 (3): 117–120.

Birch SE, Kench JG, Takano E, Chan P, Chan AL, Chiam K, Veillard AS, Stricker P., Haupt S, Haupt Y, Horvath L, Fox SB. Expression of E6AP and PML predicts for prostate cancer progression and cancer specific death. Annals of Oncology 2014;

Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P, Pedersen TR, LaRosa JC, Waters DD, DeMicco DA, Simes RJ, Keech AC, Colquhoun D, Hitman GA, Betteridge DJ, Clearfield MB, Downs JR, Colhoun HM, Gotto AM Jr, Ridker PM, Grundy SM, Kastelein JJ. Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. Journal of the American College of Cardiology 2014;  64 (5): 485–494.

Bowyer SE, Schofield DJ. The role of oncology nurse practitioners in current oncology practice and lessons for Australia. Medical Journal of Australia 2014;  200 (7): 382–384.

Bruhn MA, Townsend AR, Lee CK, Shivasami A, Price TJ, Wrin J, Arentz G, Tebbutt NC, Hocking C, Cunningham D, Hardingham JE. Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer. International Journal of Cancer 2014;  135 (3): 731–741.

Burgess NG, Williams SJ, Hourigan LF, Brown GJ, Zanati SA, Singh R, Tam W, Butt J, Byth K, Bourke MJ. A management algorithm based on outcomes of clinically significant delayed bleeding after wide-field endoscopic mucosal resection of large colonic lesions. Clinical Gastroenterology and Hepatology 2014;  12 (9): 1525–1533.

Carter HE, Martin A, Schofield D, Duchesne G, Haworth A, Hornby C, Sidhom M, Jackson M. A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy compared to three dimensional conformal radiation therapy in patients receiving radiotherapy to the prostate bed. Radiotherapy and Oncology 2014;

Carter HE, Zannino D, Simes RJ, Schofield DJ, Howard K, Zalcberg JR, Price TJ, Tebbutt NC. The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX study. European Journal of Cancer 2014;  50 (3): 535–543.

Carter J., Philp S, O'Connell R. A 5-year review of gynaecological oncology patients managed by a fast track surgery program. International Journal of Clinical Medicine 2014;  5 (1): 36–41.

Chan KH, Simpson PJ, Yong AS, Dunn LL, Chawantanpipat C, Hsu C, Yu Y, Keech AC, Celermajer DS, Ng MK. The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease—a cellular, angiographic and physiologic study. PLoS One 2014;  9 (4): e93980.

Cosman R, Brown CSB, DeBraganca KC, Khasraw M. Patterns of care in adult medulloblastoma: results of an international online survey. Journal of Neuro-Oncology 2014;  120 (1): 125–129.

Dahlen HG, Tracy S, Tracy M, Bisits A, Brown C, Thornton C. Rates of obstetric intervention and associated perinatal mortality and morbidity among low-risk women giving birth in private and public hospitals in NSW (2000-2008): a linked data population-based cohort study. BMJ Open 2014;  4 (5): e004551.

Darlow BA, Marschner SL, Donoghoe M, Battin MR, Broadbent RS, Elder MJ, Hewson MP, Meyer MP, Ghadge A, Graham P, McNeill NJ, Kuschel CA, Tarnow-Mordi WO, Benefits Of Oxygen Saturation Targeting-New Zealand (BOOST-NZ) Collaborative Group. Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes. Journal of Pediatrics 2014;

Davis RA, Dinh MM, Bein KJ, Veillard AS, Green TC. Senior work-up assessment and treatment team in an emergency department: a randomised control trial. Emergency Medicine Australasia 2014;  26 (4): 343–349.

d'Emden MC, Jenkins AJ, Li L, Zannino D, Mann KP, Best JD, Stuckey BGA, Park K, Saltevo J, Keech AC, on behalf of the FIELD Study Investigators. Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 2014;

Dietz HP, Mann KP. What is clinically relevant prolapse? An attempt at defining cutoffs for the clinical assessment of pelvic organ descent. International Urogynecology Journal 2014;  25 (4): 451–455.

Ding L, Cheng R, Hu Y, Takahashi Y, Jenkins AJ, Keech AC, Humphries KM, Gu X, Elliott MH, Xia X, Ma JX. Peroxisome proliferator-activated receptor. American Journal of Pathology 2014;  184 (10): 2709–2720.

Dinh MM, Bein KJ, Oliver M, Veillard A-S, Ivers R. Refining the trauma triage algorithm at an Australian major trauma centre: derivation and internal validation of a triage risk score. European Journal of Trauma and Emergency Surgery 2014;  40: 67–74.

Emery J, Doorey J, Jefford M, King M, Pirotta M, Hayne D, Martin A, Trevena L, Tim L, Constable R, Hawks C, Hyatt A, Hamid A, Violet J, Gill S, Frydenberg M, Schofield P. Protocol for the ProCare trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer. BMJ Open 2014;  3: e004972.

Farrell R., Gebski V, Hacker NF. Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?. International Journal of Gynecological Cancer 2014;  24 (4): 813–819.

Friedlander ML, Stockler M, O'Connell R, Voysey M, Oza A, Gillies K, Donovan H, Martyn J, Sjoquist K, Butow P, King MT, Symptom Benefit Study Group. Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the Gynecologic Cancer Intergroup Symptom Benefit study. International Journal of Gynecological Cancer 2014;  24 (5): 857–864.

Fuller NR, Carter H, Schofield D, Hauner H, Jebb SA, Colagiuri S, Caterson ID. Cost-effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care-a modelled lifetime analysis. International Journal of Obesity 2014;  38 (8): 1104–1109.

Fuller NR, Williams K, Shrestha R, Ahern AL, Holzapfel C, Hauner H, Jebb SA, Caterson ID. Changes in physical activity during a weight loss intervention and follow-up: a randomized controlled trial. Clinical Obesity 2014;

Funke-Kaiser A, Mann K, Colquhoun D, Zeller T, Hunt D, Simes J, Sullivan D, Sydow K, West M, White H, Blankenberg S, Tonkin AM, on behalf of the LIPID Study Investigators. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study. International Journal of Cardiology 2014;  172 (2): 411–418.

Glasziou PP, Irwig L, Kirby AC, Tonkin AM, Simes RJ. Which lipid measurement should we monitor? An analysis of the LIPID study. BMJ Open 2014;  4 (2): e003512.

Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effect). Metabolic mediators of the effect of body mass index, overweight and obesity on coronary heart disease and stroke: pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 2014;  383 (9921): 970–983.

Goodwin PJ, Bruera E, Stockler M. Pain in patients with cancer . Journal of Clinical Oncology 2014;  32 (16): 1637–1639.

Gray K, Barnes E, Gibbons P, Little D, Burns J. Unilateral versus bilateral clubfoot: an analysis of severity and correlation. Journal of Pediatric Orthopaedics B 2014;  23 (5): 286–399.

Greenhalf W, Ghaneh P, Neoptolemos JP, Palmer DH, Cox TF, Lamb RF, Garner E, Campbell F, Mackey JR, Costello E, Moore MJ, Valle JW, McDonald AC, Carter R, Tebbutt NC, Goldstein D, Shannon J, Dervenis C, Glimelius B, Deakin M, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Halloran CM, Mayerle J, Oláh A, Jackson R, Rawcliffe CL, Scarpe A, Bassi C, Büchler MW, and for the European Study Group for Pancreatic Cancer. Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. Journal of the National Cancer Institute 2014;  106 (1): djt347.

Grimison PS, Stockler MR, Chatfield M, Thomson DB, Gebski V, Friedlander M, Boland AL, Houghton B, Gurney H, Rosenthal M, Singhal N, Kichenadasse G, Wong SS, Lewis CR, Vasey PA, Toner GC, Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Annals of Oncology 2014;  25 (1): 143–148.

Hardikar AA, Farr RJ, Joglekar MV. Circulating microRNAs: understanding the limits for quantitative measurement by real‐time PCR. Journal of the American Heart Association 2014;  3 (e000792)

Hawkes AL, Quinn M, Gebski V, Armes J, Brennan D, Janda M, for the feMME Trial Committee, Obermair A. Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device±metformin±weight loss in endometrial cancer (feMME) trial. Contemporary Clinical Trials 2014;  39 (1): 14–21.

Hendrieckx C, Halliday JA, Bowden JP, Colman PG, Cohen N, Jenkins A, Speight J. Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics. Diabetes Research and Clinical Practice 2014;  103 (3): 430–436.

Hocking C, Hardingham J, Broadbridge V, Townsend AR, Tebbutt N, Cooper J, Ruszkiewicz A, Lee C, Price TJ. Can we accurately report PTEN status in advanced colorectal cancer?. BMC Cancer 2014;  14: 128.

Horvath AR, Lord SJ, St John A, Sandberg S, Cobbaert CM, Lorenz S, Monaghan PJ, Verhagen-Kamerbeek WD, Ebert C, Bossuyt PM, For the Test Evaluation Working Group of the European Federation of Clinical Chemistry Laboratory Medicine. From biomarkers to medical tests: the changing landscape of test evaluation. Clinica Chimica Acta 2014;  427 (1): 49–57.

Hudson HM, Lô SN, Simes RJ, Tonkin AM, Heritier S. Semiparametric methods for multistate survival models in randomised trials. Statistics in Medicine 2014;  33 (10): 1621–1645.

Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis . Nature Reviews. Rheumatology 2014;  10 (7): 437–441.

Huober J, Cole BF, Rabaglio M, Giobbie-Hurder A, Wu J, Ejlertsen B., Bonnefoi H., Forbes JF, Neven P, Láng I, Smith I., Wardley A., Price KN, Goldhirsch A, Coates AS, Colleoni M, Gelber RD, Thürlimann B, for the BIG 1-98 Collaborative and International Breast Cancer Study Groups. Symptoms of endocrine treatment and outcome in the BIG 1-98 study. Breast Cancer Research and Treatment 2014;  143 (1): 159–169.

Januszewski AS, Mason N, Karschimkus CS, Rowley KG, Best JD, O'Neal DN, Jenkins AJ. Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemia. Diabetes and Vascular Disease Research 2014;  11 (4): 262–269.

Jenkins AJ. Sometimes you have to give a man a fish. Medical Journal of Australia 2014;  200 (2): 122–123.

Jenkins AJ, Fu D, Azar M, Soner JA, Kaufman DG, Zhang S, Klein RL, Lopes-Virella MF, Ma JX, Lyons TJ. Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. Journal of Diabetes and its Complications 2014;  28 (3): 353–359.

Jonker DJ, Karapetis CS, Harbison C, O'Callaghan CJ, Tu D, Simes RJ, Malone DP, Langer C, Tebbutt N, Price TJ, Shapiro J, Siu LL, Wong RP, Bjarnason G, Moore MJ, Zalcberg JR, Khambata-Ford S. Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. British Journal of Cancer 2014;  110 (3): 648–655.

Kapellas K, Maple-Brown LJ, Jamieson LM, Do LG, O'Dea K, Brown A, Cai TY, Anstey NM, Sullivan DR, Wang H, Celermajer DS, Slade GD, Skilton MR. Effect of periodontal therapy on arterial structure and function among Aboriginal Australians. A randomized, controlled trial. Hypertension 2014;  64 (4): 702–708.

Karapetis CS, Jonker D, Daneshmand M, Hanson JE, O'Callaghan CJ, Marginean EC, Zalcberg JR, Simes J, Moore MJ, Tebbutt N, Price TJ, Shapiro JD, Pavlakis N, Gibbs P, Hazel GV, Lee U, Haq R, Virk S, Tu D, Lorimer IA. PIK3CA, BRAF and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer—results from NCIC CTG/AGITG CO.17. Clinical Cancer Research 2014;  20 (3): 744–753.

Karikios DJ, Schofield D, Salkeld G, Mann KP, Trotman J, Stockler M. The rising cost of anticancer drugs in Australia. Internal Medicine Journal 2014;  44 (5): 458–463.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N. Antiangiogenic therapy for high-grade glioma. Cochrane Database of Systematic Reviews 2014;  9: CD008218.

King MT, Stockler MR, Butow P, O'Connell R, Voysey M, Oza AM, Gillies K, Donovan HS, Mercieca-Bebber R, Martyn J, Sjoquist K, Friedlander ML. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer. International Journal of Gynecological Cancer 2014;  24 (5): 865–873.

Laurie SA, Solomon BJ, Seymour L, Ellis PM, Goss GD, Shepherd FA, Boyer MJ, Arnold AM, Clingan P, Laberge F, Fenton D, Hirsh V, Zukin M, Stockler MR, Lee CW, Chen EX, Montenegro A, Ding K, Bradbury PA. Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29. European Journal of Cancer 2014;  50 (4): 706–712.

Leonard C, Bein KJ, Latt M, Muscatello D, Veillard AS, Dinh MM. Demand for emergency department services in the elderly: an 11 year analysis of the Greater Sydney Area. Emergency Medicine Australasia 2014;  26 (4): 356–360 .

Lin HM, Castillo L, Mahon KL, Chiam K, Lee BY, Nguyen Q, Boyer MJ, Stockler MR, Pavlakis N, Marx G, Mallesara G, Gurney H, Clark SJ, Swarbrick A, Daly RJ, Horvath LG. Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer. British Journal of Cancer 2014;  110 (10): 2462–2471.

Linton A, Pavlakis N, O'Connell R, Soeberg M, Kao S, Clarke S, Vardy J, van Zandwijk N. Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales. British Journal of Cancer 2014;

Liu J, Joglekar MV, Sumer H, Hardikar AA, Teede H, Verma PJ. Integration-free human induced pluripotent stem cells from type 1 diabetes patient skin fibroblasts show upregulations of pancreas-specific microRNAs. Cell Medicine 2014;

Lwin Z, Broom A, Cosman R, Livingstone A, Sawkins K, Good P, Kirby E, Koh ES, Hovey E, on behalf of the COGNO CALD working group. Culturally and linguistically diverse patient participation in glioma research. Neuro-Oncology Practice 2014;

Mahon KL, Qu W, Devaney J, Paul C, Castillo L, Wykes RJ, Chatfield MD, Boyer MJ, Stockler MR, Marx G, Gurney H, Mallesara G, Molloy PL, Horvath LG, Clark SJ, PRime Consortium. Methylated glutathione s-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer. British Journal of Cancer 2014;

Marschner IC. Letter to the editor . Biostatistics 2014;

McBride J, Jenkins A, Liu X, Zhang B, Lee K, Berry WL, Janknecht R, Griffin C, Aston CE, Lyons T, Tomasek JJ, Ma JX. Elevated circulation levels of an anti-angiogenic SERPIN in patients with diabetic microvascular complications impairs wound healing through suppression of Wnt signaling. Journal of Investigative Dermatology 2014;  134 (6): 1725–1734.

McCarthy N, Boyle F, Zdenkowski N, Bull J, Leong E, Simpson A, Kannourakis G, Francis PA, Chirgwin J, Abdi E, Gebski V, Veillard AS, Zannino D, Wilcken N, Reaby L, Lindsay DF, Badger HD, Forbes JF, Australia and New Zealand Breast Cancer Trials Group. Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem). Breast 2014;  23 (2): 142–151.

Noushi F., Spillane AJ, Uren RF, Cooper R. A., Allwright S, Snook KL, Gillet D, Pearce AM, Gebski V. High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphy. European Journal of Surgical Oncology 2014;  39 (10): 1053–1060.

O'Carrigan B, Fournier M, Olver IN, Stockler MR, Whitford H, Toner GC, Thomson DB, Davis ID, Hanning F, Singhal N, Underhill C, Clingan P, McDonald A, Boland A, Grimison P, Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study. Internal Medicine Journal 2014;  44 (8): 813–817.

Phu A, Xu Z, Brakoulias V, Mahant N, Fung VSC, Moore GD, Martin A, Starcevic V, Krause M. Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients. Journal of Clinical Neuroscience  2014;  1 (1): 63–66.

Price TJ, Segelov E, Burge M, Haller DG, Tebbutt NC, Karapetis CS, Punt CJA, Pavlakis N, Arnold D, Gibbs P, Shapiro JD. Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013. Expert Review of Anticancer Therapy 2014;

Ransom D, Wilson K, Fournier M, Simes RJ, Gebski V, Yip D, Tebbutt N, Karapetis CS, Ferry D, Gordon S, Price TJ. Final results of Australasian Gastro-Intestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines. Annals of Oncology 2014;  25 (1): 117–121.

Rodrigo N, Wong V, Shek KL, Martin A, Dietz HP. The use of 3-dimensional ultrasound of the pelvic floor to predict recurrence risk after pelvic reconstructive surgery. Australian and New Zealand Journal of Obstetrics and Gynaecology 2014;  54 (3): 206–211.

Rosmarin D, Palles C, Church D, Domingo E, Jones A, Johnstone E, Wang H, Love S, Julier P, Scudder C, Nicholson G, Gonzalez-Neira A, Martin M, Sargent DJ, Green E, McLeod H, Zanger UM, Schwag M, Seymour MT, Thompson L, Lacas B, Boige V, Ribelles N, Afzal S, Enghusen H, Etienne-Grimaldi MC, Milano G, Wadelius M, Glimelius B, Garmo H, Gusella M, Lecomte T, Laurent-Puig, Martinez-Balibrea E, Sharma R, Garcia-Foncillas J, Kleibl Z, Morel A, Pignon JP, Midgley RS, Kerr D, Tomlinson I. Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. Journal of Clinical Oncology 2014;  32 (10): 1031–1039.

Schofield D, Cunich M, Shrestha R, Callander E, Passey M. E., Kelly S, Tanton R, Veerman L. The impact of diabetes on the labour force participation and income poverty of workers aged 45–64 years in Australia. PloS One 2014;

Schofield D, Cunich M, Shrestha R, Passey M, Kelly S, Tanton R, Veerman L. The impact of chronic conditions of care recipients on the labour force participation of informal carers in Australia: which conditions are associated with higher rates of non-participation in the labour force?. BMC Public Health 2014;  14 (1): 561.

Schofield D, Cunich MM, Shrestha RN, Passey ME, Veerman L, Callander EJ, Keely SJ, Tanton R. The economic impact of diabetes through lost labour force participation on individuals and government: evidence from a microsimulation model. BMC Public Health 2014;  14: 220.

Schofield DJ. How should we measure the impact of chronic pain? Limitations of utility measurement using the EQ-5D and SF-6D. Pain 2014;

Schofield DJ. An invited commentary on Torrance et al. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?. Pain 2014;

Schofield DJ, Callander EJ, Shrestha RN, Passey ME, Kelly SJ, Percival R. Back problems, co-morbidities and their association with wealth. Spine Journal 2014;

Schofield DJ, Callander EJ, Shrestha RN, Passey ME, Kelly SJ, Percival R. Multiple chronic health conditions and their link with wealth assets. European Journal of Public Health 2014;

Schofield DJ, Callander EJ, Shrestha RN, Passey ME, Percival R, Kelly SJ. How co-morbidities magnify the effect of arthritis on labour force participation and economic status: a costs of illness study in Australia. Rheumatology International 2014;  34 (4): 481–489.

Schofield DJ, Callander EJ, Shrestha RN, Passey ME, Percival R, Kelly SJ. Indirect economic impacts of comorbidities on people with heart disease. Circulation Journal 2014;  78 (3): 644–648.

Schulson M, Liu A, Björkman T, Quinton A, Mann K, Benzie R, Peek M, Nanan R. Mid-gestational enlargement of fetal thalami in women exposed to methadone during pregnancy. Frontiers in Surgery 2014;

Seimon RV, Espinoza D, Ivers L, Gebski V, Finer N, Legler UF, Sharma AM, James WP, Coutinho W, Caterson ID. Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease. International Journal of Obesity 2014;  38 (9): 1165–1171.

Sengupta S, Grimison P, Hayne D, Williams S, Chambers S, De Souza P, Stockler M, McJannett M, Toner G, Davis ID. ANZUP—a new co-operative cancer trials group in genito-urinary oncology. BJU International 2014;

Simes J, Becattini C, Agnelli G, Eikelboom J, Kirby AC, Mister R, Prandoni P, Brighton TA, for the INSPIRE (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism) Study Investigators. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 2014;

Sjoquist KM, Chin VT, Chantrill LA, O'Connor C, Hemmings C, Chang DK, Chou A, Pajic M, Johns AL, Nagrial AM, Biankin AV, Yip D. Personalising pancreas cancer treatment: when tissue is the issue. World Journal of Gastroenterology 2014;  20 (24): 7849–7863.

Sommeijer DW, Karapetis CS, Zalcberg JR, Tu D, Jonker DJ, Simes J, Tebbutt N, Yip D, Price TJ, O'Callaghan CJ. The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17. Acta Oncologica 2014;  53 (7): 877–884.

Stockler MR, Hilpert F, Friedlander M, King MT, Wenzel L, Lee CK, Joly F, De Gregorio N, Arranz JA, Raza Mirza M, Sorio R, Freudensprung U, Sneller V, Hales G, Pujade-Lauraine E. Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer. Journal of Clinical Oncology 2014;  32 (13): 1309–1316.

Sundaresan P, Milross C, Smith A, Evans A, Stockler MR, King MT. Factors influencing the use of RT in NSW: a qualitative study exploring consumer and health professional perspectives. Journal of Medical Imaging and Radiation Oncology 2014;

Tarnow-Mordi W, Soll RF. Probiotic supplementation in preterm infants: it is time to change practice. Journal of Pediatrics 2014;  164 (5): 959–960.

Tarnow-Mordi WO, Duley L, Field D, Marlow N, Morris J, Newnham J, Paneth N, Soll RF, Sweet D. Timing of cord clamping in very preterm infants: more evidence is needed. American Journal of Obstetrics and Gynecology 2014;  211 (2): 118–123.

Tattersall MHN, Martin AJ, Devine R, Ryan J, Jansen J, Hasting L, Boyer M, Glare P, Stockler M, Butow P. Early contact with palliative care services: a randomised trial of metastatic cancer patients with a survival expectation of less than 12 months. Journal of Palliative Care & Medicine  2014;  4 (1): 170.

Thibault-Gagnon S, Yusuf S, Langer S, Wong V, Shek KL, Martin A, Dietz HP. Do women notice the impact of childbirth-related levator trauma on pelvic floor and sexual function? Results of an observational ultrasound study. International Urogynecology Journal 2014;  25 (10): 1389–1398.

Tjokrowidjaja A, Lee CK, Houssami N, Lord S. Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis. Internal Medicine Journal 2014;  44 (8): 764–770.

Tran B, Armstrong BK, Ebeling PR, English DR, Kimlin MG, van der Pols JC, Venn A, Gebski V, Whiteman DC, Webb PM, Neale RE. Effect of vitamin D supplementation on antibiotic use: a randomized controlled trial. American Journal of Clinical Nutrition 2014;  99 (1): 156–161.

Trutnovsky G, Ulrich D, Rojas RG, Mann K, Aigmueller T, Dietz HP. The "bother" of urinary incontinence. International Urogynecology Journal 2014;  25 (7): 947–951.

Ulrich D, Guzman Rojas R, Dietz HP, Mann K, Trutnovsky G. Use of a visual analog scale for evaluation of bother from pelvic organ prolapse. Ultrasound in Obstetrics & Gynecology 2014;  43: 693–697.

Viergever RF, Karam G, Reis A, Ghersi D. The quality of registration of clinical trials: still a problem. PLoS One 2014;  9 (1): e84727.

Waldman B, Jenkins AJ, Davis TM, Taskinen MR, Scott R, O'Connell RL, Gebski VJ, Ng MK, Keech AC, on behalf of the FIELD Study investigators. HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes. Diabetes Care 2014;  37: 2351–2358.

Waterhouse M, Tran B, Armstrong BK, Baxter C, Ebeling PR, English DR, Gebski V, Hill C, Kimlin MG, Lucas RM, Venn A, Webb PM, Whiteman DC, Neale RE. Environmental, personal and genetic determinants of response to vitamin D supplementation in older adults. Journal of Clinical Endocrinology and Metabolism 2014;  99 (7): E1332–1340.

West NP, Horn PL, Pyne DB, Gebski VJ, Lahtinen SJ, Fricker PA, Cripps AW. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clinical Nutrition 2014;  33 (4): 581–487.

West TA, Kiely BE, Stockler MR. Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: a systematic review of randomised trials. European Journal of Cancer 2014;  50 (11): 1916–1924.

White HD, Tonkin A, Simes J, Stewart R, Mann K, Thompson P, Colquhoun D, West M, Nestel P, Sullivan D, Keech AC, Hunt D, Blankenberg S, for the LIPID study investigators. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID study. Journal of the American College of Cardiology 2014;  63 (4): 345–354.

White HD, Tonkin A, Simes J, Stewart RA, Mann K, Thompson P, Colquhoun D, West M, Nestel P, Sullivan D, Keech AC, Hunt D, Blankenberg S, LIPID study investigators. Reply to Letter to the Editor: Troponin I to target treatments which reduce cardiovascular risk—while waiting for Godot [letter]. Journal of the American College of Cardiology 2014;

Wojtalewicz C, Kirby A, Dietz JE. Implementation and modeling of a regional hub reception center during mass evacuation operations. Journal of Emergency Management 2014;  12 (3): 197–210.

Wong V, Shek KL, Goh J, Krause H, Martin A, Dietz HP. Cystocele recurrence after anterior colporrhaphy with and without mesh use. European Journal of Obstetrics Gynecology and Reproductive Biology 2014;  172 (1): 131–135.

Yee J, Davis GM, Beith JM, Wilcken N, Currow D, Emery J, Phillips J, Martin A, Hui R, Harrison M, Segelov E, Kilbreath SL. Physical activity and fitness in women with metastatic breast cancer. Journal of Cancer Survivorship 2014;